Home › Brain Hypoxia-Ischemia › NCT06762795
The HIEnome Study: Genome Sequencing for Perinatal HIE
Who can join
0 Days – 1 Year · All sexes
Full eligibility criteria
Inclusion Criteria: * Delivery ≥35w0d gestation * Diagnosed with moderate or severe HIE, or HIE with seizures * Undergoing total body cooling / therapeutic hypothermia * Able to provide blood or buccal samples during birth hospitalization * Admitted to Texas Children's Hospital Main, West, or Woodlands NICU Exclusion Criteria: * Parents/family not willing to allow participation * Inability to collect sufficient neonatal blood samples (in some circumstances, a buccal swab may be used as backup)
About the study
Perinatal hypoxic-ischemic encephalopathy is a rare severe condition in which neonates present with encephalopathy and a clinical history suggestive of prenatal or perinatal hypoxic-ischemic injury. Emerging evidence suggests that genetic conditions are frequently identified in cases of perinatal HIE; however, it is unclear which neonates with this diagnosis warrant genetic testing. This study will offer clinical genome sequencing to neonates with HIE who are undergoing total body cooling (therapeutic hypothermia) and their parents.
What is being tested
- Genome sequencing (genetic)
Sponsor: Baylor College of Medicine · Participants: 25 · Started: May 15, 2025
Contact the study team
- Christian Parobek, MD, PhD · Phone: 828-713-9962
- Seema Lalani, MD · Phone: 7137988921
Official record on ClinicalTrials.gov — NCT06762795
Locations in the U.S.
| Texas | Texas Children's Hospital, Houston Texas Children's Hospital, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.